|
|
造血干细胞移植治疗重型再生障碍性贫血的研究进展
|
Abstract:
异基因造血干细胞移植(allogeneic hematopoietic stem cell transplantation, allo-HSCT)是治疗重型再生障碍性贫血(severe aplastic anemia, SAA)最有效的方法之一。随着近年来异基因造血干细胞移植临床实践的规范化和单倍体相合造血干细胞移植的进展，异基因造血干细胞移植已经迎来了新时代。基于国内和国际的前沿发展，探讨当前医疗背景下SAA患者allo-HSCT的适应症、供者选择、预处理方案以及移植物抗宿主病的预防措施等移植程序对于SAA患者移植预后至关重要，本文将围绕以上SAA相关移植程序的应用进展做一综述。
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered a highly effective treatment method. Recent advancements in haploidentical hematopoietic stem cell transplantation, along with the standardization of clinical practices for allo-HSCT, have marked a new era in the field. It is essential to explore indications, donor selection, conditioning regimens, preventive measures for graft-versus-host disease and other transplantation procedures in SAA patients. These factors significantly impact the transplant prognosis for SAA patients. This article will provide a comprehensive review of the progress in SAA-related transplantation procedures, drawing on cutting-edge developments both in China and abroad.
| [1] | Alashkar, F., Oelmüller, M., Herich-Terhürne, D., et al. (2019) Immunosuppressive Therapy (IST) in Adult Patients with Acquired Aplastic Anemia (AA): A Single-Center Experience over the Past 15 Years. European Journal of Haematology, 103, 18-25. https://doi.org/10.1111/ejh.13235 |
| [2] | Foucar, C.E., Foley, D.H., Aldous, J., et al. (2023) Real-World Outcomes with Immunosuppressive Therapy for Aplastic Anemia in Patients Treated at the University of Michigan. European Journal of Haematology, 112, 424-432. https://doi.org/10.1111/ejh.14131 |
| [3] | Patel, B.A., Groarke, E.M., Lotter, J., et al. (2022) Long-Term Outcomes in Patients with Severe Aplastic Anemia Treated with Immunosuppression and Eltrombopag: A Phase 2 Study. Blood, 139, 34-43. https://doi.org/10.1182/blood.2021012130 |
| [4] | Zhang, X.H., Chen, J., Han, M.Z., et al. (2021) The Consensus from the Chinese Society of Hematology on Indications, Conditioning Regimens and Donor Selection for Allogeneic Hematopoietic Stem Cell Transplantation: 2021 Update. Journal of Hematology & Oncology, 14, Article No. 145. https://doi.org/10.1186/s13045-021-01159-2 |
| [5] | Snowden, J.A., Sánchez-Ortega, I., Corbacioglu, S., et al. (2022) Indications for Haematopoietic Cell Transplantation for Haematological Diseases, Solid Tumours and Immune Disorders: Current Practice in Europe, 2022. Bone Marrow Transplantation, 57, 1217-1239. https://doi.org/10.1038/s41409-022-01691-w |
| [6] | Kulasekararaj, A., Cavenagh, J., Dokal, I., et al. (2024) Guidelines for the Diagnosis and Management of Adult Aplastic Anaemia: A British Society for Haematology Guideline. British Journal of Haematology, 204, 784-804. https://doi.org/10.1111/bjh.19236 |
| [7] | Xu, L.P., Jin, S., Wang, S.Q., et al. (2017) Upfront Haploidentical Transplant for Acquired Severe Aplastic Anemia: Registry-Based Comparison with Matched Related Transplant. Journal of Hematology & Oncology, 10, Article No. 25. https://doi.org/10.1186/s13045-017-0398-y |
| [8] | Lu, Y., Sun, R.J., Zhao, Y.L., et al. (2018) Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable with Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation, 24, 1881-1887. https://doi.org/10.1016/j.bbmt.2018.05.015 |
| [9] | Xu, L.P., Xu, Z.L., Wang, F.R., et al. (2018) Unmanipulated Haploidentical Transplantation Conditioning with Busulfan, Cyclophosphamide and Anti-Thymoglobulin for Adult Severe Aplastic Anaemia. Bone Marrow Transplantation, 53, 188-192. https://doi.org/10.1038/bmt.2017.237 |
| [10] | Zeng, Y., Wang, S., Wang, J., et al. (2018) Optimal Donor for Severe Aplastic Anemia Patient Requiring Allogeneic Hematopoietic Stem Cell Transplantation: A Large-Sample Study from China. Scientific Reports, 8, Article No. 2479. https://doi.org/10.1038/s41598-018-20853-9 |
| [11] | ElGohary, G., El Fakih, R., De Latour, R., et al. (2020) Haploidentical Hematopoietic Stem Cell Transplantation in Aplastic Anemia: A Systematic Review and Meta-Analysis of Clinical Outcome on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (SAAWP of EBMT). Bone Marrow Transplantation, 55, 1906-1917. https://doi.org/10.1038/s41409-020-0897-2 |
| [12] | Geng, C., Liu, X., Chen, M., et al. (2020) Comparison of Frontline Treatment with Intensive Immunosuppression Therapy and HLA-Haploidentical Hematopoietic Stem Cell Transplantation for Young Patients with Severe Aplastic Anemia—A Meta Analysis. Leukemia Research, 88, Article ID: 106266. https://doi.org/10.1016/j.leukres.2019.106266 |
| [13] | Liu, L., Zhang, Y., Jiao, W., et al. (2020) Comparison of Efficacy and Health-Related Quality of Life of First-Line Haploidentical Hematopoietic Stem Cell Transplantation with Unrelated Cord Blood Infusion and First-Line Immunosuppressive Therapy for Acquired Severe Aplastic Anemia. Leukemia, 34, 3359-3369. https://doi.org/10.1038/s41375-020-0933-7 |
| [14] | Xu, L.P., Wang, S.Q., Wu, D.P., et al. (2016) Haplo-Identical Transplantation for Acquired Severe Aplastic Anaemia in a Multicentre Prospective Study. British Journal of Haematology, 175, 265-274. https://doi.org/10.1111/bjh.14225 |
| [15] | Brodsky, R.A., Jones, R.J., Fuchs, E.J., et al. (2020) Haploidentical BMT for Severe Aplastic Anemia with Intensive GVHD Prophylaxis Including Posttransplant Cyclophosphamide. Blood Advances, 4, 1770-1779. https://doi.org/10.1182/bloodadvances.2020001729 |
| [16] | Zhu, H., Luo, RM., Luan, Z., et al. (2016) Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anaemia. British Journal of Haematology, 174, 799-805. https://doi.org/10.1111/bjh.14110 |
| [17] | Gupta, V., Eapen, M., Brazauskas, R., et al. (2010) Impact of Age on Outcomes after Bone Marrow Transplantation for Acquired Aplastic Anemia Using HLA-Matched Sibling Donors. Haematologica, 95, 2119-2125. https://doi.org/10.3324/haematol.2010.026682 |
| [18] | Horan, J., Wang, T., Haagenson, M., et al. (2012) Evaluation of HLA Matching in Unrelated Hematopoietic Stem Cell Transplantation for Nonmalignant Disorders. Blood, 120, 2918-2924. https://doi.org/10.1182/blood-2012-03-417758 |
| [19] | Shin, S.H., Jeon, Y.W., Yoon, J.H., et al. (2016) Comparable Outcomes Between Younger (≤ 40 Years) and Older (> 40 Years) Adult Patients with Severe Aplastic Anemia after HLA-Matched Sibling Stem Cell Transplantation Using Fludarabine-Based Conditioning. Bone Marrow Transplantation, 51, 1456-1463. https://doi.org/10.1038/bmt.2016.171 |
| [20] | Rice, C., Eikema, D.J., Marsh, J.C.W., et al. (2019) Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50 Years or Older with Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation, 25, 488-495. https://doi.org/10.1016/j.bbmt.2018.08.029 |
| [21] | Xu, Z.L., Xu, L.P., Wu, D.P., et al. (2022) Comparable Long-Term Outcomes between Upfront Haploidentical and Identical Sibling Donor Transplant in Aplastic Anemia: A National Registry-Based Study. Haematologica, 107, 2918-2927. https://doi.org/10.3324/haematol.2022.280758 |
| [22] | 唐湘凤, 井远方, 卢伟, 等. 单倍型造血干细胞移植治疗儿童获得性重型再生障碍性贫血的临床研究[J]. 中华血液学杂志, 2019, 40(4): 301-305. |
| [23] | Zhang, Y.Y., Mo, W.J., Zuo, Y.Y., et al. (2020) Comparable Survival Outcome between Transplantation from Haploidentical Donor and Matched Related Donor or Unrelated Donor for Severe Aplastic Anemia Patients Aged 40 Years and Older: A Retrospective Multicenter Cohort Study. Clinical Transplantation, 34, e13810. https://doi.org/10.1111/ctr.13810 |
| [24] | Xu, L.P., Wang, S.Q., Ma, Y.R., et al. (2019) Who Is the Best Haploidentical Donor for Acquired Severe Aplastic Anemia? Experience from a Multicenter Study. Journal of Hematology & Oncology, 12, Article No. 87. https://doi.org/10.1186/s13045-019-0775-9 |
| [25] | Ma, Y.R., Wang, W.J., Cheng, Y.F., et al. (2020) Impact of ABO Incompatibility on Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia. Bone Marrow Transplantation, 55, 1068-1075. https://doi.org/10.1038/s41409-020-0779-7 |
| [26] | Ciurea, S.O., Cao, K., Fernandez-Vina, M., et al. (2018) The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-Specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplantation, 53, 521-534. https://doi.org/10.1038/s41409-017-0062-8 |
| [27] | Ciurea, S.O., Al Malki, M.M., Kongtim, P., et al. (2019) The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell Transplantation. Bone Marrow Transplantation, 55, 12-24. https://doi.org/10.1038/s41409-019-0499-z |
| [28] | Deotare, U., Al-Dawsari, G., Couban, S., et al. (2015) G-CSF-Primed Bone Marrow as a Source of Stem Cells for Allografting: Revisiting the Concept. Bone Marrow Transplant, 50, 1150-1156. https://doi.org/10.1038/bmt.2015.80 |
| [29] | Bacigalupo, A., Socie, G., Schrezenmeier, H., et al. (2012) Bone Marrow versus Peripheral Blood as the Stem Cell Source for Sibling Transplants in Acquired Aplastic Anemia: Survival Advantage for Bone Marrow in All Age Groups. Haematologica, 97, 1142-1148. https://doi.org/10.3324/haematol.2011.054841 |
| [30] | Passweg, J.R., Baldomero, H., Ciceri, F., et al. (2023) Hematopoietic Cell Transplantation and Cellular Therapies in Europe 2021. The Second Year of the SARS-CoV-2 Pandemic. A Report from the EBMT Activity Survey. Bone Marrow Transplant, 58, 647-658. https://doi.org/10.1038/s41409-023-01943-3 |
| [31] | Xu, L.P., Lu, D.P., Wu, D.P., et al. (2023) Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 during the SARS-CoV-2 Pandemic: A Report from the Chinese Blood and Marrow Transplantation Registry Group. Transplantation and Cellular Therapy, 29, 136.e1-136.e7. https://doi.org/10.1016/j.jtct.2022.11.011 |
| [32] | Im, H.J., Koh, K.N. and Seo, J.J. (2015) Haploidentical Hematopoietic Stem Cell Transplantation in Children and Adolescents with Acquired Severe Aplastic Anemia. Korean Journal of Pediatrics, 58, 199-205. https://doi.org/10.3345/kjp.2015.58.6.199 |
| [33] | Salas, M.Q., Atenafu, E.G., Lam, W., et al. (2020) High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in Vivo T-Cell Depletion Transplants and Long-Term Complications. Blood Cell Therapy, 3, 48-58. https://doi.org/10.31547/bct-2020-001 |
| [34] | Samarasinghe, S., Clesham, K., Iacobelli, S., et al. (2018) Impact of T-Cell Depletion Strategies on Outcomes Following Hematopoietic Stem Cell Transplantation for Idiopathic Aplastic Anemia: A Study on Behalf of the European Blood and Marrow Transplant Severe Aplastic Anemia Working Party. American Journal of Hematology, 94, 80-86. https://doi.org/10.1002/ajh.25314 |
| [35] | Peffault De Latour, R., Rocha, V. and Socié, G. (2013) Cord Blood Transplantation in Aplastic Anemia. Bone Marrow Transplantation, 48, 201-202. https://doi.org/10.1038/bmt.2012.252 |
| [36] | Childs, R.W., Tian, X., Vo, P., et al. (2021) Combined Haploidentical and Cord Blood Transplantation for Refractory Severe Aplastic Anaemia and Hypoplastic Myelodysplastic Syndrome. British Journal of Haematology, 193, 951-960. https://doi.org/10.1111/bjh.17406 |
| [37] | Yao, D., Tian, Y., Li, J., et al. (2022) Association between Haploidentical Hematopoietic Stem Cell Transplantation Combined with an Umbilical Cord Blood Unit and Graft-versus-Host Disease in Pediatric Patients with Acquired Severe Aplastic Anemia. Therapeutic Advances in Hematology, 13, 1-19. https://doi.org/10.1177/20406207221134409 |
| [38] | Sun, Y., Liu, Z., Xiao, J., et al. (2018) Autologous Cord Blood Transplantation in Children with Acquired Severe Aplastic Anemia. Pediatric Transplantation, 23, e13325. https://doi.org/10.1111/petr.13325 |
| [39] | Lu, L.L., Liu, Y.J., Yang, S.G., et al. (2006) Isolation and Characterization of Human Umbilical Cord Mesenchymal Stem Cells with Hematopoiesis-Supportive Function and Other Potentials. Haematologica, 91, 1017-1026. |
| [40] | Wu, Y.M., LuoM R.M., Cao, Y.B., et al. (2017) Improved Outcome of Haploidentical Transplantation in Severe Aplastic Anemia Using Reduced-Intensity Fludarabine-Based Conditioning. Oncotarget, 8, 83817-83830. https://doi.org/10.18632/oncotarget.19745 |
| [41] | Liu, Z., Zhang, Y., Xiao, H., et al. (2017) Cotransplantation of Bone Marrow-Derived Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: An Interim Summary for A Multicenter Phase II Trial Results. Bone Marrow Transplantation, 52, 704-710. https://doi.org/10.1038/bmt.2016.347 |
| [42] | Ding, L., Han, D.M., Zheng, X.L., et al. (2021) A Study of Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cells Transplantation Combined with Allogenic Mesenchymal Stem Cell Infusion for Treatment of Severe Aplastic Anemia in Pediatric and Adolescent Patients. Stem Cells Translational Medicine, 10, 291-302. https://doi.org/10.1002/sctm.20-0345 |
| [43] | Ding, L., Han, D.M., Zheng, X.L., et al. (2022) Infusion of Haploidentical Hematopoietic Stem Cells Combined with Mesenchymal Stem Cells for Treatment of Severe Aplastic Anemia in Adult Patients Yields Curative Effects. Cytotherapy, 24, 205-212. https://doi.org/10.1016/j.jcyt.2021.09.014 |
| [44] | Bejanyan, N., Kim, S., Hebert, K.M., et al. (2019) Choice of Conditioning Regimens for Bone Marrow Transplantation in Severe Aplastic Anemia. Blood Advances, 3, 3123-3131. https://doi.org/10.1182/bloodadvances.2019000722 |
| [45] | Xu, L.P., Liu, K.Y., Liu, D.H., et al. (2012) A Novel Protocol for Haploidentical Hematopoietic SCT without in Vitro T-Cell Depletion in the Treatment of Severe Acquired Aplastic Anemia. Bone Marrow Transplant, 47, 1507-1512. https://doi.org/10.1038/bmt.2012.79 |
| [46] | Xu, L.P., Zhang, X.H., Wang, F.R., et al. (2017) Haploidentical Transplantation for Pediatric Patients with Acquired Severe Aplastic Anemia. Bone Marrow Transplant, 52, 381-387. https://doi.org/10.1038/bmt.2016.281 |
| [47] | Xu, L.P., Xu, Z.L., Wang, S.Q., et al. (2022) Long-Term Follow-Up of Haploidentical Transplantation in Relapsed/Refractory Severe Aplastic Anemia: A Multicenter Prospective Study. Science Bulletin, 67, 963-970. https://doi.org/10.1016/j.scib.2022.01.024 |
| [48] | Li, Y., Wang, N., Zhang, X., et al. (2023) Post-Transplantation Cyclophosphamide as GVHD Prophylaxis in Allogenic Hematopoietic Stem Cell Transplantation: Recent Advances and Modification. Blood Reviews, 62, Article ID: 101078. https://doi.org/10.1016/j.blre.2023.101078 |
| [49] | Li, Y., Wang, N., Li, L., et al. (2021) Haploidentical Transplantation with Modified Post-Transplantation Cyclophosphamide for Patients with Primary Aplastic Anemia: A Multicenter Experience. Transplantation and Cellular Therapy, 27, 331.e1-331.e7. https://doi.org/10.1016/j.jtct.2021.01.018 |
| [50] | Yang, K., Gong, S., Jiang, T., et al. (2021) Haploidentical Peripheral Stem Cell Transplantation for Young Patients with Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide and Methotrexate. Transplantation and Cellular Therapy, 27, 429.e1-429.e7. https://doi.org/10.1016/j.jtct.2021.02.014 |
| [51] | Storb, R., Deeg, H.J., Farewell, V., et al. (1986) Marrow Transplantation for Severe Aplastic Anemia: Methotrexate Alone Compared with a Combination of Methotrexate and Cyclosporine for Prevention of Acute Graft-Versus-Host Disease. Blood, 68, 119-125. https://doi.org/10.1182/blood.V68.1.119.119 |
| [52] | Nash, R.A., Antin, J.H., Karanes, C., et al. (2000) Phase 3 Study Comparing Methotrexate and Tacrolimus with Methotrexate and Cyclosporine for Prophylaxis of Acute Graft-Versus-Host Disease after Marrow Transplantation from Unrelated Donors. Blood, 96, 2062-2068. |
| [53] | 费洋, 胡晓霞, 陈琪, 等. 异基因造血干细胞移植植入失败的危险因素分析[J]. 中华血液学杂志, 2020, 41(1): 64-68. |
| [54] | Li, Y., Duan, F., Xiao, H., et al. (2018) Therapeutic Outcomes of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Severe Aplastic Anemia: A Multicenter Study. Transplantation, 102, 1724-1731. https://doi.org/10.1097/TP.0000000000002200 |
| [55] | Zhang, X., Shi, Y., Huang, Y., et al. (2017) Serum Ferritin Is a Different Predictor from Transfusion History for Allogeneic Transplantation Outcome in Patients with Severe Aplastic Anemia. Hematology, 23, 291-298. https://doi.org/10.1080/10245332.2017.1390929 |
| [56] | Xu, LP., Yu, Y., Cheng, YF., et al. (2021) Development and Validation of a Mortality Predicting Scoring System for Severe Aplastic Anaemia Patients Receiving Haploidentical Allogeneic Transplantation. British Journal of Haematology, 196, 735-742. https://doi.org/10.1111/bjh.17916 |
